Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases-Reference-Cited by-同舟云学术

Serum anti‐LRPAP1 is a common biomarker for digestive organ cancers and atherosclerotic diseases

Published:2020-10-04 Issue:12 Volume:111 Page:4453-4464
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci.

Author:

Sumazaki Makoto¹^ORCID,Shimada Hideaki¹^ORCID,Ito Masaaki¹,Shiratori Fumiaki¹,Kobayashi Eiichi²,Yoshida Yoichi²,Adachi Akihiko²,Matsutani Tomoo²,Iwadate Yasuo²,Mine Seiichiro²³⁴,Machida Toshio⁴⁵,Kamitsukasa Ikuo⁶⁷,Mori Masahiro⁸,Sugimoto Kazuo⁸⁹,Uzawa Akiyuki⁸,Kuwabara Satoshi⁸,Kobayashi Yoshio¹⁰,Ohno Mikiko¹¹¹²,Nishi Eiichiro¹¹¹²,Maezawa Yoshiro¹³,Takemoto Minoru¹³¹⁴,Yokote Koutaro¹³,Takizawa Hirotaka¹⁵,Kashiwado Koichi¹⁶,Shin Hideo¹⁷,Kishimoto Takashi¹⁸,Matsushita Kazuyuki¹⁹^ORCID,Kobayashi Sohei¹⁹^ORCID,Nakamura Rika⁹²⁰,Shinmen Natsuko⁹²⁰,Kuroda Hideyuki²⁰,Zhang Xiao‐Meng⁹,Wang Hao⁹²¹,Goto Ken‐ichiro⁹,Hiwasa Takaki¹²⁹^ORCID

Affiliation:

1. Department of Gastroenterological Surgery and Clinical Oncology Toho University Graduate School of Medicine Tokyo Japan

2. Department of Neurological Surgery Graduate School of Medicine Chiba University Chiba Japan

3. Department of Neurological Surgery Chiba Prefectural Sawara Hospital Chiba Japan

4. Department of Neurological Surgery Chiba Cerebral and Cardiovascular Center Chiba Japan

5. Department of Neurosurgery Eastern Chiba Medical Center Chiba Japan

6. Department of Neurology Chiba Rosai Hospital Chiba Japan

7. Department of Neurology Chibaken Saiseikai Narashino Hospital Chiba Japan

8. Department of Neurology Graduate School of Medicine Chiba University Chiba Japan

9. Department of Biochemistry and Genetics Graduate School of Medicine Chiba University Chiba Japan

10. Department of Cardiovascular Medicine Graduate School of Medicine Chiba University Chiba Japan

11. Department of Cardiovascular Medicine Graduate School of Medicine Kyoto University Kyoto Japan

12. Department of Pharmacology Shiga University of Medical Science Shiga Japan

13. Department of Endocrinology, Hematology and Gerontology Graduate School of Medicine Chiba University Chiba Japan

14. Department of Diabetes, Metabolism and Endocrinology School of Medicine International University of Health and Welfare Chiba Japan

15. Port Square Kashiwado Clinic Kashiwado Memorial Foundation Chiba Japan

16. Department of Neurology Kashiwado Hospital Chiba Japan

17. Department of Neurosurgery Higashi Funabashi Hospital Chiba Japan

18. Department of Molecular Pathology Graduate School of Medicine Chiba University Chiba Japan

19. Division of Clinical Genetics and Proteomics Department of Laboratory Medicine Chiba University Hospital Chiba Japan

20. Medical Project Division Research Development Center Fujikura Kasei Co. Saitama Japan

21. Department of Anesthesia The First Affiliated Hospital Jinan University Guanzhou China

Funder

Japan Science and Technology Agency

Ministry of Education, Culture, Sports, Science and Technology

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14652

Reference56 articles.

1. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma

2. Titration of serump53 antibodies in 1085 patients with various types of malignant tumors

3. Perioperative Changes of Serum p53 Antibody Titer is a Predictor for Survival in Patients with Esophageal Squamous Cell Carcinoma

4. p53 molecular approach to diagnosis and treatment of esophageal squamous cell carcinoma

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum anti‑KIAA0513 antibody as a common biomarker for mortal atherosclerotic and cancerous diseases;Medicine International;2024-06-19

2. Stage-Specific Alteration and Prognostic Relationship of Serum Fumarate Hydratase Autoantibodies in Gastric Cancer;International Journal of Molecular Sciences;2024-05-17

3. Combination of high anti‐SKI and low anti‐TMED5 antibody levels is preferable prognostic factor in esophageal carcinoma;Cancer Science;2024-04-18

4. Proteomic analysis reveals LRPAP1 as a key player in the micropapillary pattern metastasis of lung adenocarcinoma;Heliyon;2024-01

5. Serum anti-PCK1 antibody levels are a prognostic factor for patients with diabetes mellitus;BMC Endocrine Disorders;2023-10-30